Page 24 - MEMOCiberdem014-ENG

CIBERDEM PLATFORMS
CIBERDEM Biobank
http://www.ciberdem.org/biobanco.php
The objective of the CIBERDEM Biobank is to make well characterised and standardised biological samples of main metabolic disorders with a high added value available to the scientific community to promote, facilitate and develop biomedical research according to the laws in force .
The CIBERDEM Biobank consists of CIBERDEM groups in the following centres:
• Hospital Clínic de Barcelona: Dr . Ramon Gomis y Dra . Anna Novials • Hospital Joan XXIII: Dr . Joan Vendrell • Hospital Sant Joan de Reus: Dr . Masana • Hospital Josep Trueta: Dr . Fernández-Real
• Hospital de Cruces: Dr . Luís Castaño • Hospital Clínico de Madrid: Dr . Serrano-Ríos • Hospital Clínico de Valencia: Dr . Carmena • Hospital Carlos Haya de Málaga: Dr . C . Soriguer • Hospital de la Santa Creu i Sant Pau: Dr . Blanco-Vaca
Donor information is stored in the BCGene computer platform . This application complies with the requirements of Organic Law on Personal Data Protection 15/1999 and will be accessible from all participating nodes to facilitate data entry by clinical teams .
In 2014, collaboration with the Red de Grupos de Estudios de la Diabetes en Atención Primaria (GEDAPS) was continued for collecting samples associated with the PREDAPS study relating to prediabetic patient follow- up, the general objective being to determine the risk of diabetes and the risk of vascular complications in prediabetic patients and identify the factors associated with these risks . It is a prospective study in which the follow-up of a cohort of prediabetic subjects and another cohort of subjects without glucose metabolism alterations is to be performed for 10 years . Male and female patients visiting primary healthcare centres who are over 29 years old and less than 75 years old and sign the informed consent have started to be recruited for that purpose .
Collection of blood samples from patients recruited for the Project was started through collaboration with CIBERDEM in the last fiscal year in order to build a biorepository of serum, plasma and buffycoat samples representative of the population affected by prediabetes . In 2014, samples were again collected from patients included in the study which, due to the availability of clinical follow-up among donors, provides a high added value to the collection, as donor samples in different phases of the disease can be analysed .
Additionally in 2014, basic collection of the biobank has been continued, incorporating new samples of the main metabolic diseases .
The following tables show the summary of the samples stored in the Biobank facilities .
24 CIBERDEM » Annual report 2014